Literature DB >> 6255412

Sequence organization of feline leukemia virus DNA in infected cells.

J I Mullins, J W Casey, M O Nicolson, N Davidson.   

Abstract

A restriction site map has been deduced of unintegrated and integrated FeLV viral DNA found in human RD cells after experimental infection with the Gardner-Arnstein strain of FeLV. Restriction fragments were ordered by single and double enzyme digests followed by Southern transfer (1) and hybridization with 32P-labeled viral cDNA probes. The restriction map was oriented with respect to the 5' and 3' ends of viral RNA by using a 3' specific hybridization probe. The major form of unintegrated viral DNA found was a 8.7 kb linear DNA molecule bearing a 450 bp direct long terminal redundancy (LTR) derived from both 5' and 3' viral RNA sequences. Minor, circular forms, 8.7 kb and 8.2 kb in length were also detected, the larger one probably containing two adjacent copies of the LTR and the smaller one containing one comtaining one copy of the LTR. Integrated copies of FeLV are colinear with the unintegrated linear form and contain the KpnI and SmaI sites found in each LTR.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6255412      PMCID: PMC324153          DOI: 10.1093/nar/8.15.3287

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  31 in total

1.  Homologies among the nucleotide sequences of the genomes of C-type viruses.

Authors:  N Quintrell; H E Varmus; J M Bishop; M O Nicholson; R M McAllister
Journal:  Virology       Date:  1974-04       Impact factor: 3.616

2.  Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests.

Authors:  P S Sarma; T Log
Journal:  Virology       Date:  1973-07       Impact factor: 3.616

3.  RD-114 virus compared with feline and murine type-C viruses released from RD cells.

Authors:  R M McAllister; M Nicolson; M B Gardner; S Rasheed; R W Rongey; W D Hardy; R V Gilden
Journal:  Nat New Biol       Date:  1973-03-21

4.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

5.  Horizontal transmission of leukemia virus and leukemia in the cat.

Authors:  W Jarrett; O Jarrett; L Mackey; H Laird; W Hardy; M Essex
Journal:  J Natl Cancer Inst       Date:  1973-09       Impact factor: 13.506

6.  Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County.

Authors:  C R Dorn; D O Taylor; R Schneider; H H Hibbard; M R Klauber
Journal:  J Natl Cancer Inst       Date:  1968-02       Impact factor: 13.506

7.  Replication of cat leukemia virus in cell cultures.

Authors:  O Jarrett; H M Laird; D Hay; G W Crighton
Journal:  Nature       Date:  1968-08-03       Impact factor: 49.962

8.  Experimental transmission of feline fibrosarcoma to cats and dogs.

Authors:  M B Gardner; R W Rongey; P Arnstein; J D Estes; P Sarma; R J Huebner; C G Rickard
Journal:  Nature       Date:  1970-05-30       Impact factor: 49.962

9.  A transmissible virus-induced lymphocytic leukemia of the cat.

Authors:  C G Rickard; J E Post; F Noronha; L M Barr
Journal:  J Natl Cancer Inst       Date:  1969-06       Impact factor: 13.506

10.  Horizontal transmission of feline leukaemia virus.

Authors:  W D Hardy; L J Old; P W Hess; M Essex; S Cotter
Journal:  Nature       Date:  1973-08-03       Impact factor: 49.962

View more
  23 in total

1.  Characterization of a cytolytic strain of equine infectious anemia virus.

Authors:  Wendy Maury; Patrick J Wright; Sarahann Bradley
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

2.  Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses.

Authors:  P R Donahue; E A Hoover; G A Beltz; N Riedel; V M Hirsch; J Overbaugh; J I Mullins
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS.

Authors:  P R Donahue; S L Quackenbush; M V Gallo; C M deNoronha; J Overbaugh; E A Hoover; J I Mullins
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Molecular analysis of several classes of endogenous feline leukemia virus elements.

Authors:  L H Soe; R W Shimizu; J R Landolph; P Roy-Burman
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

5.  Human T-cell lymphotropic virus type III shares sequence homology with a family of pathogenic lentiviruses.

Authors:  M A Gonda; M J Braun; J E Clements; J M Pyper; F Wong-Staal; R C Gallo; R V Gilden
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

6.  Genomic clones coding for some of the initial genes expressed during Drosophila development.

Authors:  B J Sina; M Pellegrini
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

7.  Sequence arrangement and biological activity of cloned feline leukemia virus proviruses from a virus-productive human cell line.

Authors:  J I Mullins; J W Casey; M O Nicolson; K B Burck; N Davidson
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

8.  Molecular cloning and cell cycle-specific regulation of a functional human thymidine kinase gene.

Authors:  H D Bradshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  Drosophila melanogaster has only one myosin alkali light-chain gene which encodes a protein with considerable amino acid sequence homology to chicken myosin alkali light chains.

Authors:  S Falkenthal; V P Parker; W W Mattox; N Davidson
Journal:  Mol Cell Biol       Date:  1984-05       Impact factor: 4.272

10.  Distinct superinfection interference properties yet similar receptor utilization by cytopathic and noncytopathic feline leukemia viruses.

Authors:  T A Reinhart; A K Ghosh; E A Hoover; J I Mullins
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.